Author: admin
-
PRIMER: No. 3 Iowa State at Arizona State
AMES, Iowa – No. 3 Iowa State opens its Big 12 dual slate on the road at Arizona State Tuesday evening. The Cyclones look to win their eighth consecutive Big 12 dual opener under head coach Kevin Dresser starting at 7:30 p.m. (CT) on ESPN+.
THE…
Continue Reading
-
Bat-borne virus linked to unexplained illnesses in Bangladesh
Infectious disease researchers have identified Pteropine orthoreoviruses (PRVs), a group of newly emergent bat-borne viruses, as the culprit for previously unexplained illness in five Bangladeshi patients, one of whom eventually…
Continue Reading
-
Amid Indus Waters Treaty suspension, Indian minister reviews power projects across Chenab basin
January 6, 2026
JAMMU – Amid the suspension of the Indus Waters Treaty with Pakistan, Union Minister for Power Manohar Lal, during a two-day visit here, reviewed the progress of hydroelectric projects being executed by the National…
Continue Reading
-
Kristen Stewart moves behind the camera to direct first feature film, ‘The Chronology of Water’
HOLLYWOOD — Kristen Stewart began her acting career at the age of 9. Now, at 35, she is at the beginning of a new phase in her career: directing.
She is excited to have made her first feature film, “The Chronology of Water.”
“You know, I’ve just…
Continue Reading
-
Brain Health Challenge: Try the MIND Diet
Welcome to Day 2 of the Brain Health Challenge. Today, we’re talking about food.
Your brain is an energy hog. Despite comprising about 2 percent of the average person’s body mass, it consumes roughly 20 percent of the body’s energy. In…
Continue Reading
-
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China – Biogen
- Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China Biogen
- BIIB: Biogen’s LEQEMBI Application Accepted in China GuruFocus
- Biogen : Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China marketscreener.com
- Biogen, Eisai say Leqembi BLA accepted in China TipRanks
- Eisai and Biogen Announce Acceptance of Biologics License Application for Subcutaneous LEQEMBI® in China Quiver Quantitative
Continue Reading
-
Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds
A large international modelling study reveals that the hidden cost of unpaid caregiving, not healthcare alone, drives the staggering long-term economic impact of diabetes across countries and income levels.
Study: The global…
Continue Reading
-
Looking Forward to Another Year of Purpose and Partnership – Samsung Newsroom Malaysia
We have said farewell to 2025 and as we look ahead and welcome a new year, I am immensely proud of what our teams across Southeast Asia and Oceania (SEAO) have achieved together so far. To…
Continue Reading
-
Mayor Mamdani Announces 3 Judicial Appointments
NEW YORK, NY — TODAY, Mayor Zohran Mamdani announced 3 new judicial appointments which will be subject to a public hearing for official appointment in January: Cary Fischer, Natalie Barros, and Andrés Casas.
“New Yorkers deserve a…
Continue Reading